IPEC e-newsletter - Excipients Insight June/July 2017 - 10-07-17

 

Inside this issue

     

Recommended reading


Trends in excipient demand

Pharma manufacturers are seeking out innovative excipients that address bioequivalence development and solubility challenges, while enhancing formulation

PharmaManufacturing.com


Wanted: New excipients to meet the demands of a challenging industry

Current trends in the pharma market, such as the discovery of increasingly lipophilic APIs, macromolecules, and biological actives have created a need for a more in-depth understanding of existing excipients, as well as the creation of new excipients, says Karen A. Coppens, Global Marketing Manager for Dow.

DrugDev.com


Roquette expands into Brazilian pharma excipient space

Ingredients manufacturer Roquette says it will acquire Blancer’s Brazil-based excipient division, Itacel, to meet market demand.

in-PharmaTechnologist.com


New antidumping/countervailing duty petitions on citric acid from Belgium, Columbia and Thailand

Archer Daniels Midland Company, Cargill, Incorporated and Tate & Lyle Ingredients America, LLC (“Petitioners”), on June 2, 2017, filed an antidumping duty petition on citric acid and certain citrate salts from Belgium, Colombia and Thailand. In addition, Petitioners filed a countervailing duty petition against Thailand. There are already existing US AD/CVD Orders on these products from the People’s Republic of China.

National Law Review

 

 

 

Copyright © 2005 - 2017 IPEC Europe - International Pharmaceutical Excipients Council